The World Health Organization is recommending against the use of the antiviral remdesivir (Veklury, Gilead) for the treatment of COVID-19. “The antiviral drug remdesivir is not suggested for patients ...
FOSTER CITY, Calif. -- The world's largest randomized trial of COVID-19 treatments found "conclusive evidence" that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has ...
Dec 2 (Reuters) - An editorial in the influential New England Journal of Medicine cites problems with a World Health Organization (WHO) study that found Gilead Sciences Inc's (GILD.O), opens new tab ...
There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...
Foster City, Calif., September 20, 2024 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rate of major adverse cardiovascular events between 30 ...
News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest - and a clamor to know how soon it might be available. Talk turned ...
The US Food and Drug Administration (FDA) should create a patient registry to track key information about COVID-19 patients treated with remdesivir, according to three Harvard Medical School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results